Exam 4 Flashcards
what are responsible for the late phase reactions in type I
cytokines releases from mast cells
anaphylaxis
an acute, hypersensitive allergic reaction to an antigen
which cytokines cause class switching to IgE
IL-4 and IL-13
intradermal tuberculin reaction
intradermal reaction to injected tuberculin proteins, looks or area of induration within 72 hrs
AIRE
autoimmune regulator, a transcription factor that facilitates expression of non-thymic proteins to test self-reactivity in the thymus
clonal anergy
supression of NFKB or IL-2 when t cells are exposed to antigen in absence of co-stimulation
what is the difference between t cells and b cells
b cells do not remain toleration, could reactivate
what is the receptor that mediates negative feeback of antibody production
inhibitory B-cell receptor CD32b
Tregs have what special surface receptor
FoxP3
tregs in cattle
gamma delta T cells
galectin
produced by treg cells, induces cell cycle arrest in effector t cells
CTLA4
produced by treg cells, induces apoptosis of effector cells
IL-10 effects
suppresses DCs and macrophages
TGF-beta effects
suppresses adaptive immune system
IDO
tryptophan deletion and cell cycle arrest in pro-inflammatory cells, may have a role in fetal tolerance
IL-22r
receptor on epithelial cells involved in tissue healing
cryptic antigens
antigens previously hidden from the immune system in immune privileged sites
CD233
epitope forms on aging RBCs, activates destruction in spleen
rheumatoid factors
autoantibodies to other Ig, common when immune complexes are formed
immunoconglutinins
autoantibodies to complement, often C2
two examples of failed regulatory control
defects in CD95 or AIRE gene, both involved in apoptosis in thymus
microchimerism
mother and fetus exchange some cells, may induce autoimmunity
three mechanisms of infection induced AD
molecular mimicry, epitope spreading “runaway train”, and bystander activation
pemphigus vulgaris
targets desmoglein 3 in deep epidermis
pemphigus foliaceus
targets desmocollin 1 in superficial epidermis
bullous pemphigoid
targets type XVII collagen in basement membrane